Professor and Chief, Infectious Diseases
University of Texas Health San Antonio
San Antonio, TX, United States
Dr. Thomas F. Patterson received his Bachelor of Arts degree from Baylor University and his Medical Doctor from the UT McGovern Medical School in Houston. He completed his internship and residency at Vanderbilt University and Yale-New Haven Hospital, and a fellowship in infectious diseases at Yale University School of Medicine.
Dr. Patterson is a Professor of Medicine and Chief, Division of Infectious Diseases and Director of the San Antonio Center for Medical Mycology and serves as the Vice-Chair for Faculty Development in the Department of Medicine.
His clinical and research interests focus on the diagnosis and treatment of fungal diseases particularly in immunocompromised hosts. He has been involved in developing new antifungal drugs and in clinical trials of new antifungal compounds and is funded by the NIH and industry for grants and contracts on drug and diagnostic development.
During the COVID-19 pandemic Dr. Patterson led he UT Health San Antonio Division of Infectious Diseases efforts in clinical management of COVID-19. He and his team were one of the highest enrolling sites for NIH supported COVID treatment trials. He was awarded the UTHSA Presidential Distinguished Research Scholar award. He currently serves as contact PI for the NIH RECOVER initiative Long COVID hub at UT Health San Antonio.
Dr. Patterson has published and lectured extensively with over 300 peer reviewed publications, chapters, books and reviews. He has served as member of the American Board of Internal Medicine, Subspecialty Committee for Infectious Diseases and is a Fellow of the American College of Physicians and the Infectious Diseases Society of America, Past-President of the Texas Infectious Disease Society, and past-President, International Immunocompromised Host Society.
He is an avid sports fan, enjoys running, cooking, gardening, and travel!
Disclosure(s): Cidara Therapeutics: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); F2G Limited: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Scynexis Inc.: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); Sfunga Therapeutics: Advisor/Consultant (Ongoing)
PW01 - Vincent T. Andriole ID Board Review Course
Tuesday, October 10, 2023
8:00 AM – 5:30 PM US ET
Tuesday, October 10, 2023
9:20 AM – 9:55 AM US ET